IL6 and experimental autoimmune encephalomyelitis: In the same year, it was reported that the effects of MSCs in experimental autoimmune encephalomyelitis are mediated by transforming growth factor-β and interleukin (IL)-6 [44], and MSCT was performed in multiple sclerosis in 2012 [45].